Top Markets
Coin of the day
Medesis Pharma S.A. Medesis Pharma S.A.

Medesis Pharma S.A.

ALMDP
Classifica tra le azioni #37493
Medesis Pharma S.A. is a biopharmaceutical firm in the clinical development... Medesis Pharma S.A. is a biopharmaceutical firm in the clinical development phase, dedicated to creating orally delivered molecular drug therapies aimed at critical medical conditions lacking effective treatments. The company's pipeline features several innovative compounds, including NanoLithium (NP03), which is currently undergoing clinical trials for Alzheimer's disease, and NanosiRNA DH, targeting Huntington's Disease. Medesis Pharma also develops NU01 Plutonium and NU02 Cesium for nuclear decorporation, alongside NP02 – NanoManganese, a radioprotection medication designed for individuals exposed to radiation from nuclear incidents. Furthermore, their portfolio encompasses NanosiRNA COVID-19, an antiviral solution for various viral infections, and NanosiRNA Resistant cancers and NanosiRNA Oncolytic virus for oncological applications. Established in 2003, the enterprise operates from its headquarters in Montpellier, France.
Prezzo delle azioni
$0.38207938
Ultima sincronizzazione: 2025-04-07
Capitalizzazione di mercato
$1.67M
Variazione (1 giorno)
-0.39%
Variazione (1 anno)
0.00%
Paese
FR
Scambia Medesis Pharma S.A. (ALMDP)

Categoria

Storico del prezzo dell'azione per Medesis Pharma S.A. (ALMDP)
Prezzo di chiusura più alto: $0.38 il 2025-04-01

Prezzo di chiusura più basso: $15.89 il 2021-02-01
Storico del prezzo dell'azione di Medesis Pharma S.A. dal 2021 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2025 7.86%
2024 -63.03%
2023 -54.06%
2022 -64.90%
2021 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE